Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 198 Records) |
Query Trace: Stroke and CYP2C19[original query] |
---|
CYP2C19 genotype and platelet aggregation test-guided dual antiplatelet therapy after off-pump coronary artery bypass grafting: A retrospective cohort study. Frontiers in cardiovascular medicine 2022 12 9 1023004. Yao Haoyi, Qin Kaijie, Liu Yun, Yang Yi, Zhu Jiaxi, Chen Anqing, Wang Zhe, Ye Xiaofeng, Zhou Mi, Li Haiqing, Qiu Jiapei, Zhao Qiang, Zhu Yunpe |
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone. Archives of pharmacal research 2022 12 46 (1): 59-64. Cho Chang-Keun, Byeon Ji-Young, Kang Pureum, Park Jung-In, Jang Choon-Gon, Lee Seok-Yong, Choi Chang-Ik, Bae Jung-Woo, Lee Yun Jeo |
Ticagrelor Aspirin vs Clopidogrel Aspirin in CYP2C19 Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Profile. Neurology 2022 12 100 (5): e497-e504. Wang Anxin, Meng Xia, Tian Xue, Zuo Yingting, Bath Philip M, Li Hao, Xie Xuewei, Jing Jing, Lin Jinxi, Wang Yilong, Zhao Xingquan, Liu Liping, Li Zixiao, Jiang Yong, Xu Jie, Wang Feng, Chen Weifeng, Cao Minghua, Li Jianhua, Wang Yongj |
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China. Genetics research 2022 11 2022 1901256. Chang Rong, Zhou Wenqin, Ye Yi, Zhang Xiaofei, Liu Yanmin, Wu Jinch |
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovascular drugs and therapy 2022 11 . Mathew Roy O, Sidhu Mandeep S, Rihal Charanjit S, Lennon Ryan, El-Hajjar Mohammed, Yager Neil, Lyubarova Radmila, Abdul-Nour Khaled, Weitz Steven, O'Cochlain D Fearghas, Murthy Vishakantha, Levisay Justin, Marzo Kevin, Graham John, Dzavik Vlad, So Derek, Goodman Shaun, Rosenberg Yves D, Pereira Naveen, Farkouh Michael |
Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among CYP2C19 Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial. Annals of internal medicine 2022 10 175 (11): 1534-1542. Wang Anxin, Xie Xuewei, Tian Xue, Johnston S Claiborne, Li Hao, Bath Philip M, Zuo Yingting, Jing Jing, Lin Jinxi, Wang Yilong, Zhao Xingquan, Li Zixiao, Jiang Yong, Liu Liping, Meng Xia, Wang Yongj |
Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack. International journal of stroke : official journal of the International Stroke Society 2023 9 17474930231202374. Kaavya Narasimhalu, Jeremy Chan, Yoong Kwei Ang, Deidre Anne De Silva, Kelvin Bryan T |
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone. Archives of pharmacal research 2023 9 . Ji-Young Byeon, Chang-Keun Cho, Pureum Kang, Se-Hyung Kim, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong L |
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science 2023 8 . Markus Ramste, Markus Ritvos, Sergei Häyrynen, Johanna I Kiiski, Mikko Niemi, Juha Sinisa |
Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial. Stroke 2023 8 . Xuewei Xie, Jing Jing, Xia Meng, S Claiborne Johnston, Philip M Bath, Zixiao Li, Xingquan Zhao, Liping Liu, Yilong Wang, Qin Xu, Anxin Wang, Yong Jiang, Hao Li, Yongjun Wang, |
CYP2C19 Loss-of-Function Variants Associated with Long-term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population. Clinical pharmacology and therapeutics 2023 8 . Peng Wu, Ziqing Liu, Zijian Tian, Benrui Wu, Jian Shao, Qian Li, Zhaoxu Geng, Ying Pan, Ke Lu, Qiang Wang, Tao Xu, Kaixin Zh |
Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis. BMC neurology 2023 8 23 (1): 303. Mingxia Li, Qianru Yang, Jiankuan Shi, Xiaolong Zhang, Hong Lin, Fangfang |
The contribution of genotype-guided selection of P2Y inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study. European journal of clinical pharmacology 2023 7 . Yan Wu, Dongbiao Yu, Lei Zhang, Yuting Wu, Bing Shu, Likun Ma, Tianlu S |
Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2023 7 195 (26): E897-E904. Jia Zhang, Anxin Wang, Xue Tian, Xia Meng, Xuewei Xie, Jing Jing, Jinxi Lin, Yilong Wang, Zixiao Li, Liping Liu, Hao Li, Yong Jiang, Xingquan Zhao, Yongjun Wa |
Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA network open 2023 6 6 (6): e2317037. Xuewei Xie, S Claiborne Johnston, Anxin Wang, Qin Xu, Philip M Bath, Yuesong Pan, Hao Li, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Yong Jiang, Liping Liu, Anding Xu, Jing Jing, Xia Meng, Yongjun Wa |
Association Between CYP2C19 Genotypes With Clinical Phenotypes and Adipokine Levels Among Ischemic Stroke Patients: A Prospective Observational Study. Cureus 2023 6 15 (5): e39265. Jitender Gairolla, Dheeraj Khurana, Phulen Sarma, Rupinder Kler, Bikash Medhi, Madhu Khullar, Manish Modi, Priyanka Naithani, Ashok Kum |
Short-term efficacy and safety of personalized antiplatelet therapy for patients with acute ischaemic stroke or transient ischaemic attack: A randomized clinical trial. British journal of clinical pharmacology 2023 5 . Mengqi Han, Weijie Jia, Yifan Wu, Jie Kuang, Jianglong Tu, Shujuan Yin, Jibiao Chen, Xiaolin Zhang, Jingyi Li, Yongsen Chen, Bin Wu, Yingping |
[Analysis of the association of CYP450 gene polymorphisms with ischemic stroke]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 500-504. Qi Lin, Liu Yongfang, Qi Meng, Peng Yingjuan, Sun Guangming, Yue Yi |
The frequency of CYP2C19 loss-of-function variants in patients with non-cardioembolic ischemic stroke or transient ischemic attack in the Dutch population. Cerebrovascular diseases (Basel, Switzerland) 2023 3 . van den Heuvel Lotte, Vermeer Henricus J, Kerkhoff Henk, Roozenbeek Bob, Zock Ell |
Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center. Cureus 2023 3 15 (2): e34737. Kambhampati Nikhil Teja, Ahamed Hisham, K K Velayudhan, David Sachin, Hakeem Sai Chandra, Pillai Gopalakrishna, Kartha Nivedit |
Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial. Frontiers in pharmacology 2023 2 13 931405. Zhang Xiaoguang, Jiang Shanshan, Xue Jie, Ding Ying, Gu Jingyu, Hu Liang, Xu Xushen, Li Zhizhang, Kong Yuming, Li Youmei, Zhu Xiaoqiong, Yue Yunh |
Analysis of CYP2C19 gene polymorphism and influencing factors of pharmacological response of clopidogrel in patients with cerebral infarction in Zhejiang, China. Frontiers in cardiovascular medicine 2023 2 10 1020593. Mo Yijun, Lu Yao, Guo Fei, Wu Aihua, Weng Yueso |
Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention. Circulation journal : official journal of the Japanese Circulation Society 2023 2 . Sawayama Yuichi, Tomita Yukinori, Kohyama Soji, Higo Yosuke, Kodama Kenji, Asada Kohei, Yagi Noriaki, Fukuyama Megumi, Hayashi Atsushi, Shioyama Wataru, Sakai Hiroshi, Ozawa Tomoya, Isono Tetsuichiro, Hira Daiki, Yamamoto Takashi, Morita Shin-Ya, Nakagawa Yoshihi |
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial. EClinicalMedicine 2023 12 67 102357. Anxin Wang, Xue Tian, Xuewei Xie, Hao Li, Jing Jing, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Yongjun Wang, Xia Me |
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies. Cardiovascular drugs and therapy 2023 12 . Sarah Cargnin, Federica Ferrari, Salvatore Terrazzi |
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. medRxiv : the preprint server for health sciences 2023 11 . Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, Kyung Min Lee, Zhenyu Lu, Julie A Lynch, Scott L DuVall, Jason L Vassy, Stephen W Waldo, John H Cleator, Thomas M Maddox, Daniel J Rader, Themistocles L Assimes, Scott M Damrauer, Philip S Tsao, Kyong-Mi Chang, Deepak Voora, Jay Giri, Sony Tute |
Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2. Journal of the American Heart Association 2023 10 e031611. Chunjuan Wang, Weili Jia, Jing Jing, Xia Meng, Anxin Wang, Qin Xu, Xinmiao Zhang, Yuesong Pan, Xuewei Xie, S Claiborne Johnston, Philip M Bath, Jinxi Lin, Yong Jiang, Hao Li, Yilong Wang, Xingquan Zhao, Liping Liu, Zixiao Li, Yongjun Wang, |
Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction. Neurology 2023 1 . Liu Huihui, Jing Jing, Wang Anxin, Xu Qin, Meng Xia, Li Hao, Li Zixiao, Wang Yongj |
The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis. Clinical and translational science 2024 4 17 (4): e13792. Mohitosh Biswas, Md Shahadat Hossain, Tahsin Ahmed Rupok, Md Sabbir Hossain, Chonlaphat Sukas |
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial. Stroke and vascular neurology 2024 1 . Xinmiao Zhang, Jing Jing, Anxin Wang, Xuewei Xie, S Claiborne Johnston, Hao Li, Philip M Bath, Qin Xu, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Yong Jiang, Liping Liu, Weifeng Chen, Xuhai Gong, Jianhua Li, Xinsheng Han, Xia Meng, Yongjun Wa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: